Iron overload in reticuloendothelial systems of pediatric oncology patients who have undergone transfusions: MR observations

被引:12
作者
Emy, PY
Levin, TL
Sheth, SS
RuzalShapiro, C
Garvin, J
Berdon, WE
机构
[1] COLUMBIA PRESBYTERIAN MED CTR,BABIES & CHILDRENS HOSP,DEPT PEDIAT RADIOL,NEW YORK,NY 10032
[2] COLUMBIA PRESBYTERIAN MED CTR,BABIES & CHILDRENS HOSP,DEPT RADIOL,NEW YORK,NY 10032
关键词
D O I
10.2214/ajr.168.4.9124106
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
OBJECTIVE. Pediatric oncology patients who undergo intensive chemotherapy develop anemia caused by myeloid suppression that necessitates transfusions that, in turn, cause iron deposition in the reticuloendothelial system, We describe MR imaging of iron overload in pediatric patients who underwent such chemotherapy and who have solid and hematologic tumors. MATERIALS AND METHODS. The MR appearance of the liver, spleen, and bone marrow was evaluated in 13 children with both solid (n = 10) and hematologic (n = 3) malignant lesions using known criteria for the presence of iron deposition. Findings were correlated with transfusional history, chemotherapeutic regimens, and ferritin levels. RESULTS. MR imaging obtained after chemotherapy and transfusional therapy revealed signs of iron deposition in the liver and spleen, particularly on T2-weighted images, Bone marrow signal intensity varied among patients. Pancreatic signal intensity was normal. Ferritin levels were elevated in all patients. CONCLUSION. Reticuloendothelial system iron deposition present in follow-up MR imaging of pediatric solid and hematologic malignant lesions reflected the intensity of the chemotherapeutic regimen, the degree of myeloid suppression, and the resultant transfusional requirements. Such iron deposition appeared to have no effect on cardiac, liver, or pancreatic function.
引用
收藏
页码:1011 / 1015
页数:5
相关论文
共 17 条
[1]
MAGNETIC-RESONANCE-IMAGING OF TRANSFUSIONAL HEPATIC IRON OVERLOAD [J].
BONDESTAM, S ;
LAMMINEN, A ;
ANTTILA, VJ ;
RUUTU, T ;
RUUTU, P .
BRITISH JOURNAL OF RADIOLOGY, 1994, 67 (796) :339-341
[2]
MAGNETIC-RESONANCE IMAGING OF TRANSFUSIONAL HEMOSIDEROSIS COMPLICATING THALASSEMIA MAJOR [J].
BRASCH, RC ;
WESBEY, GE ;
GOODING, CA ;
KOERPER, MA .
RADIOLOGY, 1984, 150 (03) :767-771
[3]
EFFECT OF HEMATOPOIETIC GROWTH-FACTORS ON MR-IMAGES OF BONE-MARROW IN CHILDREN UNDERGOING CHEMOTHERAPY [J].
FLETCHER, BD ;
WALL, JE ;
HANNA, SL .
RADIOLOGY, 1993, 189 (03) :745-751
[4]
BIOLOGIC DIFFERENCES BETWEEN NEURO-BLASTOMA STAGES-IV-S AND STAGE-IV - MEASUREMENT OF SERUM FERRITIN AND E-ROSETTE INHIBITION IN 30 CHILDREN [J].
HANN, HWL ;
EVANS, AE ;
COHEN, IJ ;
LEITMEYER, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (08) :425-429
[5]
IMASHUKU S, 1988, AM J PEDIAT HEMATOL, V10, P39
[6]
IRON DEPOSITION IN CRANIAL BONE-MARROW WITH SICKLE-CELL DISEASE - MR ASSESSMENT USING A FAT-SUPPRESSION TECHNIQUE [J].
KANEKO, K ;
HUMBERT, JH ;
KOGUTT, MS ;
ROBINSON, AE .
PEDIATRIC RADIOLOGY, 1993, 23 (06) :435-438
[7]
MRI MARROW OBSERVATIONS IN THALASSEMIA - THE EFFECTS OF THE PRIMARY DISEASE, TRANSFUSIONAL THERAPY, AND CHELATION [J].
LEVIN, TL ;
SHETH, SS ;
RUZALSHAPIRO, C ;
ABRAMSON, S ;
PIOMELLI, S ;
BERDON, WE .
PEDIATRIC RADIOLOGY, 1995, 25 (08) :607-613
[8]
LEVIN TL, 1995, PEDIATR RADIOL, V25, P614, DOI 10.1007/BF02011829
[9]
MRI OF HEPATIC IRON DEPOSITION IN PATIENTS WITH RENAL-TRANSPLANT [J].
MILLER, FH ;
FISHER, MR ;
SOPER, W ;
GORE, RM .
GASTROINTESTINAL RADIOLOGY, 1991, 16 (03) :229-233
[10]
RED AND YELLOW MARROW IN THE FEMUR - AGE-RELATED-CHANGES IN APPEARANCE AT MR IMAGING [J].
MOORE, SG ;
DAWSON, KL .
RADIOLOGY, 1990, 175 (01) :219-223